Siegfried Holding AG
SFZN
Rankning i aktier
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Aktiekurs
$88.34
Marknadsvärde
$3.87B
Förändring (1 dag)
1.68%
Förändring (1 år)
-12.97%
Land
CH
Handel Siegfried Holding AG (SFZN)
Kategori
Healthcare
EPS för Siegfried Holding AG (SFZN)
EPS per 2026 TTM: 0
Enligt Siegfried Holding AGs senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) 0. Vid slutet av 2026 hade bolaget ett EPS på 0, lika med EPS från 2026 som var 0.
EPS-historik för Siegfried Holding AG från 2002 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2025 | $4.85 | 18.12% |
| 2024 | $4.11 | -87.02% |
| 2023 | $31.64 | -21.09% |
| 2022 | $40.10 | 60.83% |
| 2021 | $24.93 | 52.56% |
| 2020 | $16.34 | 23.03% |
| 2019 | $13.28 | -3.35% |
| 2018 | $13.74 | 30.30% |
| 2017 | $10.55 | 49.52% |
| 2016 | $7.05 | -28.70% |
| 2015 | $9.89 | -1.42% |
| 2014 | $10.04 | -40.57% |
| 2013 | $16.89 | 168.36% |
| 2012 | $6.29 | 123.93% |
| 2011 | $2.81 | -154.60% |
| 2010 | $-5.15 | -58.42% |
| 2009 | $-12.38 | -51.03% |
| 2008 | $-25.28 | -258.81% |
| 2007 | $15.92 | 65.86% |
| 2006 | $9.60 | -4.54% |
| 2005 | $10.05 | 90.16% |
| 2004 | $5.29 | -66.53% |
| 2003 | $15.80 | 5.55% |
| 2002 | $14.96 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
